SBFM Q1 2017 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q1 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$108,990

Net Income

-$195,702

EPS (Diluted)

$-39140.40

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$108,037

Free Cash Flow

-$108,037

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$23,409

Total Liabilities

$284,452

Stockholders' Equity

-$261,043

Cash & Equivalents

$17,143

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$108,990	-$69,682	-56.4%
Net Income	-$195,702	-$305,294	+35.9%